Physician profile
Markenzie Lyon
NPI 1215662382
$1,204.81
in general payments reported to CMS, 2019-2025
11 companies · $293 in 2025
The $293 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $46.17 · 2023: $633 · 2024: $233 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,158.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $247.69 | 2023-2025 | Azstarys |
| Axsome Therapeutics, INC. | $224.09 | 2023 | Auvelity |
| Supernus Pharmaceuticals, INC. | $157.40 | 2023-2025 | Qelbree, Qelbree |
| Otsuka America Pharmaceutical, INC. | $136.30 | 2023 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $124.80 | 2025 | |
| Lilly USA, LLC | $109.96 | 2024 | Mounjaro |
| Neurelis, INC. | $90.16 | 2024 | Valtoco |
| Ironshore Pharmaceuticals INC. | $60.26 | 2022-2024 | Jornay Pm |
| Abbvie INC. | $22.48 | 2022 | |
| Tris Pharma INC | $15.86 | 2024 | Dyanavel Xr |
| Collegium Pharmaceutical, INC. | $15.81 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Markenzie Lyon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.